Search
TAS-106
go.drugbank.com/drugs/DB06656InvestigationalTAS-106 is a new nucleoside antimetabolite. TAS-106 has demonstrated strong antitumor activity without serious toxicity in nude rat models bearing human tumours .
Tenidap
go.drugbank.com/drugs/DB13481ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSPI-166
go.drugbank.com/drugs/DB05859ExperimentalIt has demonstrated the ability to reduce the growth of rat hepatomas, which is like human hepatomas, are resistant to established anti-cancer agents. … PI-166 is a small organic compound with specific avidity to liver cancer cells.
Nifenazone
go.drugbank.com/drugs/DB13407ExperimentalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSProglumetacin
go.drugbank.com/drugs/DB13527InvestigationalCategories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSMofebutazone
go.drugbank.com/drugs/DB13629ExperimentalCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidalnor-NOHA
go.drugbank.com/drugs/DB02381InvestigationalN-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
Synonyms: N-hydroxy-nor-arginine, N-hydroxy-nor-L-arginineInhibitor of P38 Kinase
go.drugbank.com/drugs/DB01953ExperimentalThis compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. … This drug is known to target mitogen-activated protein kinase 14.